We observed an analogous decrease in RPA2 hyperphosphorylation in MDA-MB231 breast cancer cells transiently depleted in PARG by siRNA and treated with 2 mM HU for 24 h, and this hyperphosphorylation was restored in the presence of a PARP inhibitor (data not shown). This evidence concerns the gene RPA2 and breast carcinoma.